Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 100 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 31 participants
Very low

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

Fatigue · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 119 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

Disease activity · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 184 participants
Moderate

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 121 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

Fatigue · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 104 participants
Low

Summary of findings table for oral immunoglobulin vs control

Definite necrotizing enterocolitis (NEC) during study period · preventing necrotizing enterocolitis in preterm and low birth weight neonates

Summary of findings table for oral immunoglobulin showed no clear difference in definite necrotizing enterocolitis (NEC) during study period compared with control (low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 0.84 [0.57, 1.25]
3 studies · 1840 participants
Low

Summary of findings table for oral immunoglobulin vs control

Definite necrotizing enterocolitis (NEC) during study period ‐ IgA/IgG · preventing necrotizing enterocolitis in preterm and low birth weight neonates

It is very uncertain whether summary of findings table for oral immunoglobulin changes definite necrotizing enterocolitis (NEC) during study period ‐ IgA/IgG compared with control (very low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 0.08 [0, 1.39]
1 study · 179 participants
Very low

Summary of findings table for oral immunoglobulin vs control

Definite necrotizing enterocolitis (NEC) during study period ‐ IgG · preventing necrotizing enterocolitis in preterm and low birth weight neonates

Summary of findings table for oral immunoglobulin showed no clear difference in definite necrotizing enterocolitis (NEC) during study period ‐ IgG compared with control (low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 0.95 [0.63, 1.42]
2 studies · 1661 participants
Low

Summary of findings table for oral immunoglobulin vs control

Definite NEC after study period · preventing necrotizing enterocolitis in preterm and low birth weight neonates

It is very uncertain whether summary of findings table for oral immunoglobulin changes definite NEC after study period compared with control (very low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 1.3 [0.47, 3.6]
2 studies · 1661 participants
Very low

Summary of findings table for oral immunoglobulin vs control

NEC‐related surgery during study period · preventing necrotizing enterocolitis in preterm and low birth weight neonates

It is very uncertain whether summary of findings table for oral immunoglobulin changes NEC‐related surgery during study period compared with control (very low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 0.21 [0.02, 1.75]
2 studies · 311 participants
Very low

Summary of findings table for oral immunoglobulin vs control

NEC‐related deaths during study period · preventing necrotizing enterocolitis in preterm and low birth weight neonates

It is very uncertain whether summary of findings table for oral immunoglobulin changes NEC‐related deaths during study period compared with control (very low certainty).

1 finding from 1 review

Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
RR 1.1 [0.47, 2.59]
3 studies · 1840 participants
Very low

Summary of findings table 8: Comfrey root extract vs placebo

Pain VAS sum (decrease) on active standardized movement (mm) · patients with acute lower and upper back pain

1 finding from 1 review

Herbal medicine for low‐back pain 2014 · Cochrane Headline outcomes only
no estimate extracted
120 participants
Low

Summary of findings table ‐ Planned hospital birth vs Planned home birth

Maternal mortality ‐ not reported · Pregnant women at low risk of complications

The review found no eligible studies for this question.

1 finding from 1 review

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found